Mach7 Technologies Ltd (ASX: M7T) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Mach7 Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $83.23 million
P/E Ratio 1,428.57
Dividend Yield 0.00%
Shares Outstanding 241.24 million
Earnings per share -0.022
Dividend per share N/A
Year To Date Return -13.75%
Earnings Yield 0.07%
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

Mach7 Technologies Ltd (ASX: M7T)
Latest News

four excited doctors with their hands in the air
Share Gainers

Why the Mach7 (ASX:M7T) share price is pushing higher on Monday

This growing healthcare company has just won a new contract...

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Small Cap Shares

2 highly rated small cap ASX shares to watch

Keep an eye on these small cap ASX shares...

Read more »

Washing on a Hills Hoist
Share Market News

ASX company boss finally exits after 98% wiped off share price

Everyone has used or swung from this company's iconic product, but its shareholders have had a miserable time the past…

Read more »

Image of fund managers on laptops with share price chart overlaid
Share Market News

Fund managers are buying these ASX shares

Fund managers have been loading up on these ASX shares...

Read more »

facebook thumbs up sign with a man in the background
Small Cap Shares

2 exciting small cap ASX shares analysts rate highly

If small caps are your game, then you might want to check out these ones...

Read more »

falling healthcare asx share price represented by doctor grimacing at x-ray
Share Market News

The Mach7 (ASX:M7T) share price slips despite strong IT healthcare outlook

A strong oulook in IT healthcare is failing to lift this imaging platform provider today

Read more »

asx share price spark represented by smiling lady holding sparkler
Small Cap Shares

2 growing small cap ASX shares brokers rate as buys

Brokers appear to believe these small cap ASX shares could have bright futures...

Read more »

Chalk drawing of a risk bag and a reward bag on set of scales
Growth Shares

Why this fund likes these 3 ASX shares

The fund manager of Clime Capital Ltd (ASX:CAM) believes that these 3 ASX shares are buys, including Mach7 Technologies Ltd…

Read more »

a surprised investor reading about an asx share price in a newspaper
Small Cap Shares

3 exciting small cap ASX shares to watch

Whispir Ltd (ASX:WSP) and these exciting small cap ASX shares could have bright futures ahead of them. Here's why...

Read more »

Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market
Healthcare Shares

Mach7 (ASX:M7T) share price edges higher after positive update

The Mach7 Technologies Ltd (ASX: M7T) share price is rising today despite announcing a contract win. Here's what the company…

Read more »

Super Retail share price upgrade buy re-rating A drawing of a a superhero businessman in fron of a cityscape in silhoutte, indicating a share price earnings super cycle
Small Cap Shares

2 exciting small cap ASX shares tipped for big things

Bigtincan Holdings Ltd (ASX:BTH) and this small cap ASX share could be quality options for investors with a high tolerance for…

Read more »

Five stars
Share Gainers

Big brokers think these 5 ASX shares can outperform the market

Mineral Resources (ASX: MIN) and 3P Learning (ASX: 3PL) are among 5 ASX shares that brokers say could outperform the market…

Read more »

Frequently Asked Questions

M7T ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Mach7 Technologies Ltd

Mach7 Technologies Ltd (ASX: M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. Its systems create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. This allows healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence.

Mach7 has more than 150 customers in 15 countries and derives a majority of its revenue from North America.

M7T Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
02 May 2025 $0.35 $0.00 0.00% 110,298 $0.35 $0.35 $0.35
01 May 2025 $0.35 $0.01 2.99% 284,083 $0.34 $0.36 $0.34
30 Apr 2025 $0.34 $0.02 6.25% 904,877 $0.33 $0.38 $0.33
29 Apr 2025 $0.32 $-0.01 -3.03% 222,584 $0.33 $0.34 $0.32
28 Apr 2025 $0.33 $0.01 3.08% 151,578 $0.33 $0.33 $0.33
24 Apr 2025 $0.33 $0.00 0.00% 107,559 $0.33 $0.33 $0.33
23 Apr 2025 $0.33 $-0.01 -3.03% 506,918 $0.33 $0.33 $0.33
22 Apr 2025 $0.33 $0.00 0.00% 97,038 $0.33 $0.33 $0.33
17 Apr 2025 $0.33 $0.00 0.00% 86,323 $0.33 $0.33 $0.32
16 Apr 2025 $0.33 $0.01 3.13% 122,105 $0.32 $0.33 $0.32
15 Apr 2025 $0.32 $0.02 6.56% 83,117 $0.31 $0.32 $0.31
14 Apr 2025 $0.31 $0.00 0.00% 176,764 $0.29 $0.32 $0.29
11 Apr 2025 $0.31 $-0.01 -3.17% 68,033 $0.31 $0.31 $0.31
10 Apr 2025 $0.32 $0.02 6.78% 485,871 $0.30 $0.32 $0.30
09 Apr 2025 $0.30 $-0.02 -6.45% 156,310 $0.32 $0.32 $0.29
08 Apr 2025 $0.31 $0.00 0.00% 126,370 $0.31 $0.31 $0.31
07 Apr 2025 $0.31 $-0.01 -3.13% 437,974 $0.31 $0.31 $0.28
04 Apr 2025 $0.32 $-0.01 -3.03% 458,989 $0.33 $0.33 $0.32

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
31 Dec 2024 Eliot Siegel Buy 112,012 $44,143
On-market trade.
12 Dec 2024 Mike Lampron Buy 46,000 $16,330
On-market trade.
09 Dec 2024 Mike Lampron Issued 800,000 $284,000
Issue of securities. 2,223,000 Performance Rights
05 Dec 2024 Robert Bazzani Buy 54,700 $19,998
On-market trade.
03 Dec 2024 Robert Bazzani Buy 27,395 $9,999
On-market trade.
02 Dec 2024 Robert Bazzani Buy 53,333 $19,962
On-market trade.
28 Nov 2024 Rebecca Thompson Buy 400,000 $148,000
On-market trade.
19 Nov 2024 Robert Bazzani Expiry 225,000 $81,000
Options expired.
19 Nov 2024 Eliot Siegel Expiry 25,000 $9,000
Options expired.
19 Nov 2024 Mike Lampron Expiry 750,000 $270,000
Options expired.
30 Sep 2024 Mike Lampron Expiry 402,185 $223,212
As advised by the company. 1,423,000 Performance Rights, lapsed
21 May 2024 Robert Bazzani Buy 29,400 $19,944
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Eliot L Siegel Non-Executive Director Aug 2018
Dr. Siegel is a thought leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and also works for the Veterans Affairs Maryland Healthcare System, in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. He is a pioneer and co-founder of United Theranostics, a company created to bring state-of-the-art radiopharmaceuticals to patients for cancer therapy. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organisation as well as the American College of Radiology and the Society of Imaging Informatics in Medicine. He is also a Board member of Carestream Health and serves on advisory boards in medical imaging. He us Risk Management Committee member. Former directorships (last 3 years): Carestream Health.
Mr Mike Lampron Chief Operating OfficerChief Executive OfficerManaging Director Mar 2019
Mr. Lampron is the CEO of Mach7 Technologies. With over 20 years of experience in business and operational management for Healthcare IT companies, Michael brings experience ranging from private start-up organizations as well as established companies such as IBM and GE. Michael was previously the Chief Executive Officer for a National Teleradiology Company and has ability to drive results through a combination of astute analysis, innovative execution and cross-functional teamwork. Michael is responsible for our customers' success while driving excellence throughout Mach7. Former directorships (last 3 years): Watchtower Consultants, LLC.
Mr Robert John Bazzani Non-Executive ChairmanNon-Executive Director Jan 2020
Mr Bazzani spent 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, Rob was a member of KPMG's National Executive Committee (NEC), which oversees and is responsible for the Firm's turnover, strategic decision making, profitability and operations. Rob has a track record of leading and growing businesses. He has played a role in advising clients (public, private, and global subsidiaries) on commercial matters, public transitions, corporate governance, investment banking and law, M&A and has engaged with Government and Regulators. With experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, technology, property, insurances and consumer & industrial markets. He is Risk Management Committee member.
Ms Rebecca Thompson Non-Executive Director Nov 2023
Ms Thompson has more than 25 years of financial markets experience gained at global investment banks, listed companies and a fintech start-up. Rebecca's executive career included seven years at J.P, Morgan as the Head of Corporate Broking followed by a role at KPMG Australia as the Head of Capital Advisory and most recently Head of Investor Relations for CSR Limited (ASX:CSR). Rebecca has a skillset across equities, property, and foreign exchange with experience in the real estate, building materials, healthcare, resources and software industries. Stakeholder relations, communications, sustainability and financial analysis are core competencies Other current directorships: Independent Community Living Australia (ICLA), Non-Executive Director; MarketMeter, Non-Executive Director. He is risk Management Committee Chair.
Mr Tony Panther Company Secretary Feb 2023
-
Tony Panther Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
National Nominees Limited 32,877,317 13.63%
Sandhurst Trustees Ltd (Jmfg Consol A/C) 31,114,880 12.90%
J P Morgan Nominees Australia Pty Limited 27,668,371 11.47%
HSBC Custody Nominees (Australia) Limited 22,684,257 9.40%
Citicorp Nominees Pty Limited 9,721,484 4.03%
Ubs Nominees Pty Ltd 9,233,020 3.83%
Pt Dwi Satrya Utama 4,392,959 1.82%
Padmalwar Prakash 3,569,921 1.48%
Chew & Partners (Import & Export) Pte Ltd 2,900,074 1.20%
Perco Group Pty Ltd (F S P A/C) 2,840,000 1.18%
Microequities Asset Management Pty Ltd (Microeqts Nanocap No 11 A/C) 2,823,641 1.17%
BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) 1,718,707 0.71%
Supernatural Super Pty Ltd (The Supernatural Super A/C) 1,715,500 0.71%
Albert Liong Pak-Fai 1,544,189 0.64%
Bpnt Pty Ltd (Heaney Family Super Fund A/C) 1,539,283 0.64%
Ty Webb Pty Ltd (Ty Webb A/C) 1,339,444 0.56%
BNP Paribas Noms Pty Ltd 1,303,411 0.54%
Mrs Jennifer Lee Pilcher 1,294,856 0.54%
62 Darlinghurst Road Pty Ltd 1,000,000 0.41%
HSBC Custody Nominees (Australia) Limited (Gsco Customers A/C) 964,287 0.40%

Profile

since

Note